Loading...
S100A8 is a Novel Therapeutic Target for Anaplastic Thyroid Carcinoma
CONTEXT: Anaplastic thyroid carcinoma (ATC) is one of the most deadly human malignancies. It is 99% lethal, and patients have a median survival of only 6 months after diagnosis. Despite these grim statistics, the mechanism underlying the tumorigenic capability of ATC cells is unclear. OBJECTIVE: S10...
Saved in:
| Published in: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Endocrine Society
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318889/ https://ncbi.nlm.nih.gov/pubmed/25423568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2988 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|